Novo

Novo is a provider of investment and asset management services for the start-ups.

Business Model:

Revenue: $0

Employees: 201-500

Detailed Novo Information

Geographic Data

Novo headquarters map

Address: Tuborg Havnevej 19

City: Hellerup

State: central jutland

Zip: 2900

Country: DK

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

2,993,709Website Global Rank

4,919Website Monthly Traffic

Twitter Followers

Description

Novo is a provider of investment and asset management services for the start-ups.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
3/2022 Qure AI Series C 0
6/2012 Santaris Pharma Venture Round 12M
12/2012 Rainier Therapeutics Series A 20M
3/2023 Clever Care Health Plan Inc. Series C 0
2/2022 Biomason Series C 0
7/2014 Sonion Venture Round -
5/2013 IVERIC bio Private Equity Round 125M
9/2019 STipe Therapeutics Series A 21.8M
4/2021 Halodoc Series C 0
12/2004 CymaBay Therapeutics Series B 44M
4/2023 Alentis Therapeutics Series C 0
5/2019 Oxford BioMedica Post-IPO Equity -
2/2022 Centauri Therapeutics Series A 0
7/2021 Aristea Therapeutics Series B 0
4/2010 Archimedes Pharma Series C 99M
1/2017 Macrophage Pharma Series A 0
4/2010 Orexo Post-IPO Equity -
1/2011 Adenium Biotech ApS Seed Round -
9/2010 Tobira Therapeutics Series B 31M
1/2007 Lux Biosciences Series A 30.5M
11/2022 Breye Therapeutics Seed Round 0
9/2014 Pulmologix Venture Round 12.4M
11/2018 Precirix Series A 41.9M
5/2013 IVERIC bio Private Equity Round 50M
2/2016 Minervax Venture Round 2.5M
2/2016 Synlab Venture Round -
5/2020 Exscientia Series C 60M
10/2018 Galecto Series C 90.2M
2/2013 Avilex Pharma Venture Round -
11/2017 Outpost Medicine, LLC Series A 20M
6/2007 7TM Pharma Series D 22M
7/2019 Forendo Pharma Venture Round 0
10/2019 Reapplix Venture Round 3.7M
5/2014 Tarsa Therapeutics Series B 0
7/2015 KalVista Pharmaceuticals Series B 33M
8/2007 IVERIC bio Series A 36M
4/2020 Kebotix Series A 0
9/2016 Reapplix Venture Round 3M
3/2021 ZELP Series A 10M
7/2022 Inspirna, Inc.(formerly Rgenix, Inc.) Series D 0
7/2012 PTC Therapeutics Private Equity Round 30M
10/2013 Galecto Series B 6.3M
7/2020 Bolt Biotherapeutics Series C 93.5M
1/2002 Symphogen Series B 0
1/2021 Verve Therapeutics Series B 94M
10/2019 Disc Medicine Series A 50M
12/2014 Acesion Pharma Series B 2.5M
6/2001 BioMimetic Therapeutics Venture Round -
4/2019 Inozyme Series A 67.4M
6/2006 Lux Biosciences Series A 8.4M
5/2020 Hyperbio Therapeutics Venture Round -
4/2023 ADCendo Series A 0
3/2018 NMD Pharma Series A 47M
8/2011 KalVista Pharmaceuticals Series A 13.2M
6/2020 Freeline Series C 80M
7/2008 Cytochroma Series C 0
8/2018 Therachon Series B 60M
4/2018 Inventiva Pharma Post-IPO Equity 44.4M
7/2015 PROCEPT BioRobotics Series D 0
12/2014 Glionova Series A 5.7M
12/2020 Edgewise Therapeutics Series C 95M
8/2018 MDLIVE Venture Round 50M
6/2021 Quanta Series D 0
3/2003 Corus Pharma Series B 40M
9/2004 Arakis Limited Series C 51.6M
1/2004 PTC Therapeutics Series E 35M
11/2021 Clever Care Health Plan Venture Round -
12/2001 Cytochroma Series B 2.2M
7/2020 ISD-Immunotech Venture Round -
11/2004 Symphogen Series C 0
1/2022 Medical Knowledge Group Venture Round -
6/2015 Cogent Biosciences Series B 65M
1/2012 Chr. Hansen Post-IPO Secondary 711.3M
5/2019 Tempus Series F 0
9/2013 Acacia Pharma Series B 23.5M
7/2017 Antag Therapeutics Series A 3.1M
11/2003 Protein Forest Series A 19M
10/2019 Allievex Series A -
10/2019 Clario Private Equity Round -
5/2014 LYSOGENE Series A 22M
11/2020 Stargazer Pharmaceuticals Series A 0
4/2017 Cirius Therapeutics Series A 0
5/2015 Biosyntia Seed Round 1.9M
12/2020 Hemab Seed Round -
7/2007 Reata Pharmaceuticals Series E 25M
1/2018 Aligos Therapeutics Series A 100M
4/2014 Nora Therapeutics Series B 18M
3/2023 FIRE1 Venture Round 0
5/2013 Symphogen Private Equity Round 0
1/2016 Tarveda Therapeutics Series C 38M
6/2021 BBI Group Venture Round -
11/2019 WCG Private Equity Round -
6/2016 Verona Pharma Post-IPO Equity 65.6M
10/2012 Affimed Series D 20.1M
4/2012 Inogen Venture Round 20M
1/2020 VectivBio Series A 35M
2/2023 Spruce Biosciences Post-IPO Equity 0
5/2017 AFYX Therapeutics Series A 17.6M
1/2023 Evosep Venture Round 0
5/2018 Biosyntia Series A 4.7M
9/2001 PTC Therapeutics Series D 0
7/2020 Verona Pharma Private Placement 200M
11/2005 PTC Therapeutics Private Equity Round 26.6M
12/2018 Aristea Therapeutics Series A 15M
9/2018 BioPhero Seed Round 3.5M
5/2021 AMSilk Series C 0
7/2010 Reata Pharmaceuticals Venture Round 0
6/2016 Inspirna, Inc.(formerly Rgenix, Inc.) Series B 33M
9/2020 Syndesi Therapeutics Series A 7M
10/2010 Synosia Therapeutics Series C 0
10/2019 Arcellx Series B 0
6/2021 Glycomine Series B 0
11/2007 AnaptysBio Series B 0
11/2022 Roslin Technologies Series A 12.3M
9/2019 Inventiva Pharma Post-IPO Equity 9.1M
7/2021 Availity Secondary Market -
8/2019 Glycomine Series B 0
6/2020 Checkmate Pharmaceuticals Series C 85M
3/2021 Exscientia Series C 0
1/2007 Synosia Therapeutics Venture Round 32.5M
9/2014 Adaptimmune Series A 0
9/2020 ESCAPE Bio Venture Round 73M
1/2011 Symphogen Venture Round 0
1/2023 LePure Biotech Series C -
1/2014 Minervax Venture Round 4M
10/2020 Rappta Therapeutics Series A 10.6M
8/2022 Disc Medicine Post-IPO Equity 0
11/2004 BioMimetic Therapeutics Series C 25.7M
9/2003 Conforma Therapeutics Series C 30M
2/2012 Apollo Endosurgery Series B 0
5/2022 Engimmune Therapeutics Seed Round 15.8M
6/2004 PTC Therapeutics Series E 0
7/2021 Muna Therapeutics Series A 0
5/2021 Chromologics Seed Round 0
7/2021 Genomatica Series C 0
4/2009 ProteinSimple Series C 10M
12/2009 PTC Therapeutics Venture Round 50M
1/2019 Minervax Grant 5M
10/2017 Harmony Biosciences Venture Round 0
10/2014 Forendo Pharma Series A 0
8/2022 MedGenome Venture Round 0
6/2007 Logical Therapeutics Series B 30M
4/2011 Cianna Medical Series B 0
7/2022 Biosyntia Series B 11.7M
6/2018 Inthera Bioscience Series A 0
10/2015 Symphogen Debt Financing 0
12/2020 Tempus Series G 200M
7/2017 ESCAPE Bio Series A 63M
9/2022 Kate Farms Series C 75M
12/2005 CardioOptics Series B 20.5M
7/2020 Reapplix Series A 22.9M
5/2022 Nuvig Therapeutics Series A 47M
3/2022 Rondo Therapeutics Series A 0
3/2016 Outpost Medicine Series A 41M
4/2010 Altheos Series A 20M
3/2013 PTC Therapeutics Private Equity Round 60M
4/2020 Avalyn Pharma Series B 35.5M
7/2017 VYNE Therapeutics Series C 50.5M
3/2023 Chromologics Seed Round 0
5/2022 Invetx Series B 0
8/2018 Cirius Therapeutics Series A 9M
10/2020 MycoWorks Series B 0
2/2020 MycoWorks Series A 0
5/2006 Celltrix Venture Round 3.9M
5/2020 IO Biotech Debt Financing 0
9/2021 Disc Medicine Post-IPO Equity 0
12/2009 IVERIC bio Series B 30M
2/2012 Altheos Series A 12.5M
5/2004 Panacos Pharmaceuticals Post-IPO Equity 0
9/2011 Orphazyme Series A 0
2/2020 Spruce Biosciences Series B 88M
10/2005 Salmedix Series C 0
9/2021 Disc Medicine Series B 90M
2/2023 Hemab Series B 0
5/2021 Noom Series F 540M
10/2001 Cytochroma Series B 7.6M
9/2012 Karus Therapeutics Series B 7.6M
11/2020 The Protein Brewery Series A 0
10/2009 Lux Biosciences Series B 50M
7/2021 Hemab Series A 0
2/2007 Inogen Series D 22M
1/2020 NorthSea Therapeutics Series B 40M
10/2021 BIOMILQ Series A 0
1/2021 IO Biotech Series B 0
9/2020 Galecto Series D 0
5/2023 Ray Therapeutics Series A 0
9/2019 Nkarta Therapeutics Series B 114M
5/2014 iRhythm Technologies Series E 27.3M
3/2020 Tempus Series G 0
2/2021 Cyteir Therapeutics Series C 0
7/2020 Preventice Solutions Series B 0
1/2022 Zhenge Biotech Series C 100M
11/2022 iECURE Series A 0
4/2015 Merus Series C 79.1M
6/2018 NBE-Therapeutics Series B 0
3/2021 StrideBio Series B 0
9/2018 Morphic Therapeutic Series B 0
12/2016 HepaRegeniX Series A 9.5M
4/2021 ADCendo Series A 61.8M
8/2020 Mission Bio Series C 0
7/2020 Praxis Precision Medicines Series C 0
5/2021 Esco Lifesciences Series A 0
5/2010 Logical Therapeutics Series C 16.9M
6/2006 Reata Pharmaceuticals Series D 0
7/2008 AlloCure Series A 14.5M
4/2021 Exscientia Series D 225M
10/2003 Nuevolution Series B 0
1/2017 NeRRe Therapeutics Series B 28.6M
5/2003 BioMimetic Therapeutics Series B 5M
9/2020 Chromologics Seed Round 0
2/2022 NMD Pharma Venture Round 0
3/2022 Precirix Series B 0
1/2010 Alios BioPharma Venture Round 1M
11/2017 Orphazyme Post-IPO Equity 0
3/2012 Tarsa Therapeutics Series B 28M
11/2013 Delenex Therapeutics Series A 8M
9/2018 Forendo Pharma Venture Round 0
8/2006 Cabrellis Pharmaceuticals Series A 27.5M
7/2011 Vantia Series B 6.5M
4/2014 Spinifex Pharmaceuticals Series C 45M
5/2017 Inthera Bioscience Series A 0
3/2021 Deep Branch Biotechnology Series A 0
7/2011 HTG Molecular Diagnostics Series D 0
8/2021 Doctor Anywhere Series C 0
4/2004 Corus Pharma Series C 0
2/2017 Tarveda Therapeutics Series D 30M
5/2021 Hummingbird Bioscience Series C 0
3/2014 ZS Pharma Series D 0
1/2022 Verana Health Series E 0
1/2017 Avalyn Pharma Series A 0
5/2017 Genoa Pharmaceuticals Series A 62M
5/2021 Numab Series C 110.6M
1/2020 Aligos Therapeutics Series B 125M
5/2010 Nanoference Venture Round -
1/2021 Corwave Series C 43.2M
1/2016 NMD Pharma Grant 358.3k
8/2018 Tel Aviv Stock Exchange Venture Round -
11/2007 F-Star Therapeutics Series A 4.4M
4/2012 AlloCure Series B 25M
9/2018 Envirotainer Private Equity Round -
6/2007 Serentis Series A 20.5M
2/2019 Bolt Series B 54M
6/2021 Tribune Therapeutics Venture Round -
7/2015 Dades Venture Round -
1/2016 Acesion Pharma Venture Round 6M
8/2020 NREP Venture Round -
8/2019 LanzaTech Series E 72M
12/2016 Hoba Therapeutics Seed Round 2M
8/2013 ObsEva Series A 34.5M
2/2023 Aquafortus Series A 0
5/2013 Xellia Pharmaceuticals Venture Round -
2/2020 Inventiva Pharma Post-IPO Equity 16.4M
10/2019 Cyteir Therapeutics Series B 40.2M
1/2022 Metagenomi Series B 0
6/2023 Octave Series C 0
8/2020 ReViral Series C 0
3/2017 ConvaTec Post-IPO Equity 1.3B
1/2017 Amra Venture Round 8.9M
3/2021 BioPhero Series A 16.8M
6/2006 MediQuest Therapeutics Series A 0
12/2009 ProteinSimple Venture Round 4M
2/2021 Vestaron Series B 0
6/2019 AFYX Therapeutics Debt Financing 13M
3/2007 Amira Pharmaceuticals Series B 25M
8/2022 Vestaron Series C 0
9/2019 Edgewise Therapeutics Series B 50M
10/2020 VectivBio Equity 110M
6/2013 Akebia Therapeutics Series C 0
12/2017 NorthSea Therapeutics Series A 29.4M
12/2004 Novexel Series A 53.6M
10/2018 Inspirna, Inc.(formerly Rgenix, Inc.) Series C 40M
6/2019 Vestaron Series B 0
6/2016 F2G Series E 60M
4/2023 AMSilk Series C 0
2/2023 Elo Life Systems Series A 0
10/2018 Milestone Pharmaceuticals Series D 80M
4/2021 The Renewable Energy Partnership Venture Round -
12/2015 Inthera Bioscience Seed Round 0
4/2016 Entasis Therapeutics Series B 50M
10/2019 INBRACE Series C 45M
1/2014 IVERIC bio Post-IPO Equity 41.7M
12/2022 Doctor Anywhere Series C 0
12/2005 Light Sciences Oncology Series A 32M
3/2017 Orphazyme Venture Round 0
10/2020 Evotec Post-IPO Equity 293.6M
9/2014 Affimed Series E 0
2/2011 Orphazyme Seed Round -
11/2016 Corwave Series B 17.1M
8/2008 Serentis Series A 10.1M
1/2007 Cytochroma Series C 0
7/2016 NMD Pharma Venture Round 3M
11/2021 Asgard Therapeutics Seed Round 0
10/2019 Draupnir Bio Venture Round 33M
4/2014 SI-BONE Venture Round 33M
6/2020 Antag Therapeutics Venture Round 0
12/2021 21st.BIO Venture Round 97.1M
5/2016 Clario Venture Round -
1/2023 Metagenomi Series B 0
2/2017 Evotec Post-IPO Equity 96.1M
12/2008 Epitherapeutics Funding Round -
12/2012 NeRRe Therapeutics Series A 18.4M
12/2001 Nuevolution Series A 0
9/2021 Orbis Medicines Venture Round -
1/2006 Symphogen Series D 0
1/2020 HepaRegeniX Series B 12.2M
5/2022 Vestaron Series C 0
1/2012 Galecto Seed Round -
5/2005 BioMimetic Therapeutics Series C 11.8M
1/2015 Nkarta Therapeutics Series A 11M
11/2018 Mirum Pharmaceuticals Series A 120M
11/2016 Acesion Pharma Series C 10.1M
10/2010 ProteinSimple Series F 20M
6/2023 Octave Series C 0
5/2023 Ray Therapeutics Series A 0
4/2023 Alentis Therapeutics Series C 0
4/2023 ADCendo Series A 0
4/2023 AMSilk Series C 0
3/2023 FIRE1 Venture Round 0
3/2023 Clever Care Health Plan Inc. Series C 0
3/2023 Chromologics Seed Round 0
2/2023 Aquafortus Series A 0
2/2023 Hemab Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors
Announced Date Name Price
11/2022 KabaFusion
1/2022 The Ritedose Corporation
6/2021 BBI Group
2/2021 Altasciences
5/2019 Oxford BioMedica
7/2014 Sonion A/S

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research